Today’s Solutions: July 25, 2024

Detecting cancer before it spreads too far means that treatment is more likely to be successful, thus significantly increasing the patient’s chances of survival. However, for many types of cancer, early diagnosis is very complicated, which makes the disease a leading cause of death worldwide.

Seeking to provide a solution scientists developed an AI-supported blood test that can detect more than 50 types of cancer before clinical symptoms emerge. Now, the researchers behind the medical innovation say that the test is accurate enough to be rolled out as a screening test.

Expected to be piloted by NHS England this fall, the blood test is primarily intended for people at higher risk of the disease, including patients over 50 years old. As reported by The Guardian, it can accurately identify multiple types of cancers that are difficult to detect in the early stages. Among these are head and neck, ovarian, pancreatic, and some blood cancers.

The test works by examining chemical changes (methylation patterns) in fragments of genetic code — known as cell-free DNA (cfDNA) — that tumors shed into the bloodstream. The entire process is conducted using a machine learning algorithm — a type of artificial intelligence.

As part of the latest study, the scientists analyzed the performance of the test in 2,823 people with cancer and 1,254 people without. The findings showed that the test correctly identified when cancer was present in 51.5 percent of cases, across all stages of the disease, and wrongly detected cancer in only 0.5 percent.

The team also found that the test’s sensitivity for solid tumors without screening options, including pancreatic, esophageal, and liver cancers, was almost double (65.6 percent) than for solid tumors with screening options such as breast, cervical, and prostate cancer. The test also correctly identified the origin of the cancer in 88.7 percent of cases.

“Finding cancer early, when treatment is more likely to be successful, is one of the most significant opportunities we have to reduce the burden of cancer,” said Dr. Eric Klein, first author on the research. “These data suggest that, if used alongside existing screening tests, the multi-cancer detection test could have a profound impact on how cancer is detected and, ultimately, on public health.”

The results of the NHS trial, which will include 140,000 participants, are expected by 2023.

Study source: Annals of Oncology — Multi-cancer early detection test using an independent validation set

Solutions News Source Print this article
More of Today's Solutions

Ecuador’s historic court ruling grants Quito’s Machángara river t...

BY THE OPTIMIST DAILY EDITORIAL TEAM On July 7th, an Ecuadorian court ruled that pollution violates the rights of the Machángara River, which flows ...

Read More

Don’t feed bread to ducks! Here’s what to serve instead

BY THE OPTIMIST DAILY EDITORIAL TEAM When venturing out into the Great Outdoors, it’s important never to feed the wildlife because they can become ...

Read More

These bladeless wind turbines could revolutionize the renewable sector

Bladeless wind turbines may sound counterintuitive, but a new startup aims to prove that these devices could reinvent the way we harness wind power ...

Read More

Revel at the most detailed image of our universe yet

Here at The Optimist Daily, we have been sharing every exciting step of the James Webb Telescope’s journey, from its long-awaited launch, to when ...

Read More